NON-SMALL CELL LUNG CANCER STAGE IIIA

Clinical trials for NON-SMALL CELL LUNG CANCER STAGE IIIA explained in plain language.

Never miss a new study

Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIA trials appear

Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug aims to shrink lung tumors before surgeons operate

Disease control Recruiting now

This study is testing whether a targeted drug called trastuzumab deruxtecan can shrink tumors in people with a specific type of lung cancer (HER2-positive) before they have surgery to remove them. The goal is to see if giving the drug first makes the surgery more effective by kil…

Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

NON-SMALL CELL LUNG CANCER STAGE IIIA

Get alerted when new NON-SMALL CELL LUNG CANCER STAGE IIIA trials appear

New drug aims to shrink lung tumors before surgeons operate